Impact of Budesonide Irrigations on Patients With Chronic Rhinosinusitis and Impact on Sinus Surgery Rates

NCT03519061 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Unable to obtain FDA exemption

Conditions

Chronic Sinus Infection
Chronic Sinusitis
Chronic Sinusitis - Ethmoidal, Posterior
Chronic Sinus Congestion

Interventions

DRUG: Budesonide

Sponsor

Kaiser Permanente